Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients
about
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactamsInterindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidationRifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjectsUnderstanding and preventing drug-drug and drug-gene interactions.Contribution of N-glucuronidation to efavirenz elimination in vivo in the basal and rifampin-induced metabolism of efavirenz.Initiating antiretrovirals during tuberculosis treatment: a drug safety review.The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patientsEffects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacinEffect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacinRegulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol eliminationAdvances in Drug Discovery and Development for Pediatric Tuberculosis.Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.Rifampin combination therapy for nonmycobacterial infections.Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients.Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius.BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without TuberculosisMechanisms and the clinical relevance of complex drug-drug interactionsAn update on metabolism studies using human hepatocytes in primary cultureEffect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies
P2860
Q24631021-D52C35AF-89E9-4EE1-99DE-CDC23CDEEE7BQ24648578-89D69885-5B5E-42C8-8684-1D7C34AAA7C1Q30834393-3F8B2045-974B-4BB8-8B88-923385E49C9AQ34299005-3414E784-2D33-4CB5-9083-524BAC8DB1E5Q34415944-12992A27-30AA-461B-B897-4D97CA6CEA31Q34737523-152248AC-4188-4AD0-88DB-17B7F599917BQ35043048-D570E30E-4D63-45AB-8B48-9491DD0F7FA7Q35129048-9DD74C00-F501-4430-BE33-16B54E0EE4ADQ35738885-54AEDA87-18C0-4809-93E9-F1E26AA18D48Q35912661-BBDB344A-E677-407D-9BE9-F89B39D2E9EFQ36728692-B7E73486-66A8-4A9C-9B80-164F931C7F5FQ36951149-3829A358-4DEC-4562-81DD-C5B77018BC8DQ37134041-4E766B2E-91E8-48B3-ABC2-3EA96E45866CQ37247660-A65E18F9-B2F7-49E1-AE04-7CA6BB9BA0B8Q37672039-CC09CF31-784B-468D-B976-5EF6F485547DQ38207924-0FDED831-283D-4012-9359-6B7742BAF5A2Q40095703-E46B94D7-6C90-4F2D-A48D-D478D0872726Q40694902-DA1AA28A-AF46-436E-8656-F4E1E04C53E8Q46719094-AA47F50C-9B6E-46A9-B462-58450986CA45Q53851250-BEC809D1-9800-4C7A-A000-943D5FF73DE0Q56829837-E7925B4C-6DB0-4848-B4E7-C3D64FF7661FQ57490721-378571E8-E2CF-4B7B-97A2-7708BA8014B7Q58680978-8FC007AC-9F4B-4519-818B-85067BD6922AQ59127470-25A7337F-F314-4FBC-BE0E-EA5BB3D397B9
P2860
Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Induction of zidovudine glucur ...... picin in HIV-infected patients
@ast
Induction of zidovudine glucur ...... picin in HIV-infected patients
@en
type
label
Induction of zidovudine glucur ...... picin in HIV-infected patients
@ast
Induction of zidovudine glucur ...... picin in HIV-infected patients
@en
prefLabel
Induction of zidovudine glucur ...... picin in HIV-infected patients
@ast
Induction of zidovudine glucur ...... picin in HIV-infected patients
@en
P2093
P2860
P1476
Induction of zidovudine glucur ...... picin in HIV-infected patients
@en
P2093
B C Foster
D W Cameron
K D Gallicano
V K Shukla
P2860
P304
P356
10.1046/J.1365-2125.1999.00987.X
P407
P577
1999-08-01T00:00:00Z